Press Releases

Press Releases

This marcus evans forum will help delegates to give a more coherent, efficient and comprehensive view on the whole formulation process of protein, peptides and vaccines (from pre-formulation, formulation, production, manufacturing and delivery).  The event will be held on 6th and 8th of June 2016 in Barcelona, Spain. The delegates…

Press Releases

This marcus evans forum will help delegates to progress on IDMP projects with already some lessons learnt and practices to share for those who are less advanced in the journey. The event will be held on 13th - 15th of April 2016 in Frankfurt, Germany. This 3rd Edition IDMP Compliance…

Press Releases

This marcus evans forum will help delegates to manage efficiently their Alliance Management, structure their role in the company, improve the process and tools to use, but also consider a range of different partnership models in order to face the differences and have the possibility to react and adapt to…

Press Releases

PeptiDream Inc., a public Tokyo-based biopharmaceutical company today announced a multi-target discovery and optimization collaboration with US-based Genentech Inc., (“Genentech”), a member of the Roche Group. PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to identify macrocyclic/constrained peptides against multiple targets of interest selected by Genentech, and…

Press Releases

Biogen Inc. today announced it will report fourth quarter and year end 2015 financial results on Wednesday, January 27, 2016, before the financial markets open. Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:30 am EST.…

Press Releases

AVEO Oncology and EUSA Pharma, a newly-established specialty pharmaceutical business with global reach, today announced an exclusive license agreement in which AVEO has granted EUSA Pharma European rights to tivozanib for the treatment of advanced renal cell carcinoma (“RCC”). The agreement also includes a number of additional territories outside North…

Press Releases

Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN®  technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections…

Press Releases

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today announced the resignation of Martin Shkreli from the position of Chief Executive Officer and the appointment of Ron Tilles to the position of Interim Chief Executive Officer. Mr. Tilles will…

Press Releases

Vanda Pharmaceuticals Inc. today announced that it has appointed Gian Piero Reverberi to the role of Senior Vice President, Acting Chief Commercial Officer and European General Manager.  Mr. Reverberi was previously Vanda's Senior Vice President and European General Manager and replaces Tom Gibbs, Vanda's former Senior Vice President and Chief…

Press Releases

Mallinckrodt plc, a leading global specialty biopharmaceuticals company, today announced that its President and Chief Executive Officer, Mark Trudeau, has been nominated to the Board of Directors for TE Connectivity, a $12 billion world leader in connectivity, based in Switzerland. Trudeau will stand for election at TE Connectivity's 2016 Annual…